+499.5%
MRNA vs MOS
-17.5%
+516.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MOS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +1.4% | -3.6% | -3.1% |
| 7D | +5.5% | +9.5% | -4.1% | -0.2% |
| 30D | +158.7% | +10.4% | +148.3% | +135.9% |
| 3M | +182.1% | +12.9% | +169.2% | +155.1% |
| 6M | +151.8% | +1.2% | +150.6% | +129.4% |
| YTD | +393.6% | +9.3% | +384.2% | +349.3% |
| 1Y | +499.5% | -18.0% | +517.4% | +450.4% |
| All | +499.5% | -17.5% | +516.9% | +450.4% |
Cumulative growth
Daily Returns
Daily percentage return beside MOS.
Daily Out/Under-Performance
Portfolio return minus MOS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MOS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MOS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling